Free Trial
NASDAQ:CSCI

COSCIENS Biopharma (CSCI) Stock Price, News & Analysis

COSCIENS Biopharma logo
$3.94 -0.02 (-0.61%)
Closing price 07/25/2025 03:47 PM Eastern
Extended Trading
$3.86 -0.08 (-1.93%)
As of 07/25/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About COSCIENS Biopharma Stock (NASDAQ:CSCI)

Key Stats

Today's Range
$3.90
$3.92
50-Day Range
$3.33
$4.33
52-Week Range
$1.96
$6.77
Volume
1,107 shs
Average Volume
5,136 shs
Market Capitalization
$12.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CSCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for COSCIENS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

CSCI Stock News Headlines

CSCI COSCIENS Biopharma Inc.
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
See More Headlines

CSCI Stock Analysis - Frequently Asked Questions

COSCIENS Biopharma's stock was trading at $2.77 at the beginning of the year. Since then, CSCI shares have increased by 42.1% and is now trading at $3.9360.

COSCIENS Biopharma Inc. (NASDAQ:CSCI) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($1.16) EPS for the quarter. The business earned $1.50 million during the quarter. COSCIENS Biopharma had a negative trailing twelve-month return on equity of 101.01% and a negative net margin of 194.50%.

Shares of CSCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that COSCIENS Biopharma investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Last Earnings
5/13/2025
Today
7/26/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CSCI
CIK
1113423
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.80)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.31 million
Net Margins
-194.50%
Pretax Margin
-189.00%
Return on Equity
-101.01%
Return on Assets
-43.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.88
Quick Ratio
2.54

Sales & Book Value

Annual Sales
$9.59 million
Price / Sales
1.29
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.49 per share
Price / Book
1.13

Miscellaneous

Outstanding Shares
3,150,000
Free Float
3,144,000
Market Cap
$12.40 million
Optionable
N/A
Beta
0.76
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CSCI) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners